Cargando…

Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice

Visceral leishmaniasis (VL) caused by Leishmania donovani and L. infantum is a potentially fatal disease. To date there are no registered vaccines for disease prevention despite the fact that several vaccines are in preclinical development. Thus, new strategies are needed to improve vaccine efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agallou, Maria, Athanasiou, Evita, Kammona, Olga, Tastsoglou, Spyros, Hatzigeorgiou, Artemis G., Kiparissides, Costas, Karagouni, Evdokia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902045/ https://www.ncbi.nlm.nih.gov/pubmed/31849951 http://dx.doi.org/10.3389/fimmu.2019.02749

Ejemplares similares

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8(+) T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
por: Athanasiou, Evita, et al.
Publicado: (2017)

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis
por: Margaroni, Maritsa, et al.
Publicado: (2017)

Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine
por: Agallou, Maria, et al.
Publicado: (2017)

Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses
por: Margaroni, Maritsa, et al.
Publicado: (2023)

Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis
por: Agallou, Maria, et al.
Publicado: (2023)

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
por: Agallou, Maria, et al.
Publicado: (2014)

Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis
por: Agallou, Maria, et al.
Publicado: (2016)

Transcriptional Profiling of Leishmania infantum Infected Dendritic Cells: Insights into the Role of Immunometabolism in Host-Parasite Interaction
por: Margaroni, Maritsa, et al.
Publicado: (2022)

A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with Leishmania infantum
por: Agallou, Maria, et al.
Publicado: (2020)

Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
por: Kammona, Olga, et al.
Publicado: (2020)

Recent Developments in Hyaluronic Acid-Based Hydrogels for Cartilage Tissue Engineering Applications
por: Tsanaktsidou, Evgenia, et al.
Publicado: (2022)

microCLIP super learning framework uncovers functional transcriptome-wide miRNA interactions
por: Paraskevopoulou, Maria D., et al.
Publicado: (2018)

Manatee: detection and quantification of small non-coding RNAs from next-generation sequencing data
por: Handzlik, Joanna E., et al.
Publicado: (2020)

VCAM-1 and ICAM-1 Serum Levels as Markers of Relapse in Visceral Leishmaniasis
por: Makis, Alexandros, et al.
Publicado: (2017)

DIANA-miTED: a microRNA tissue expression database
por: Kavakiotis, Ioannis, et al.
Publicado: (2021)

Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2
por: Agallou, Maria, et al.
Publicado: (2022)

DIANA-microT 2023: including predicted targets of virally encoded miRNAs
por: Tastsoglou, Spyros, et al.
Publicado: (2023)

Biomimetic Cell-Laden MeHA Hydrogels for the Regeneration of Cartilage Tissue
por: Tsanaktsidou, Evgenia, et al.
Publicado: (2020)

Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis
por: Forrester, Sarah, et al.
Publicado: (2019)

Impact of Helicobacter pylori Infection and Its Major Virulence Factor CagA on DNA Damage Repair
por: Kontizas, Eleftherios, et al.
Publicado: (2020)

Peryton: a manual collection of experimentally supported microbe-disease associations
por: Skoufos, Giorgos, et al.
Publicado: (2020)

DIANA-miRPath v4.0: expanding target-based miRNA functional analysis in cell-type and tissue contexts
por: Tastsoglou, Spyros, et al.
Publicado: (2023)

DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts
por: Karagkouni, Dimitra, et al.
Publicado: (2020)

Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice
por: Kaur, Sukhbir, et al.
Publicado: (2016)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Transcriptomic Analysis of Fish Hosts Responses to Nervous Necrosis Virus
por: Toubanaki, Dimitra K., et al.
Publicado: (2022)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
por: Molaie, Soheila, et al.
Publicado: (2019)

Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis
por: Anderson, Jennifer M, et al.
Publicado: (2006)

Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
por: Mutile, Muendo Charity, et al.
Publicado: (2021)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

PlasmiR: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value
por: Tastsoglou, Spyros, et al.
Publicado: (2021)

Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice
por: Dayakar, Alti, et al.
Publicado: (2017)

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis
Publicado: (1995)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Visceral Leishmaniasis Treatment, Italy
por: Gradoni, Luigi, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_2u07pv45i4tqnc6cce5qc0sdn4